# Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia

> **NCT05608928** · PHASE2 · UNKNOWN · sponsor: **Tropical Gastroenterology & Nutrition Group (TROPGAN)** · enrollment: 76 (estimated)

## Conditions studied

- Environmental Enteropathy

## Interventions

- **DIETARY_SUPPLEMENT:** VSL#3
- **DEVICE:** Capscan device
- **COMBINATION_PRODUCT:** Placebo

## Key facts

- **NCT ID:** NCT05608928
- **Lead sponsor:** Tropical Gastroenterology & Nutrition Group (TROPGAN)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2022-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05608928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05608928, "Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05608928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*